Published in Clin Exp Immunol on May 01, 1974
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
Lymphocyte receptors. II. Receptors for rabbit IgM on human T lymphocytes. Immunology (1976) 2.06
Idiotypic analysis of lymphocytes in vitro. II. Genetic control of T-helper cell responsiveness to anti-idiotypic antibody. J Exp Med (1976) 1.71
Reactivity and crossreactivity of mouse helper T cells to malaria parasites. Immunology (1977) 1.36
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17
T and CR+ lymphocyte profile in leprosy and the effect of treatment. Infect Immun (1976) 1.10
Characteristics and function of Fc receptors on human lymphocytes. Immunology (1982) 1.09
Spleen cell changes during fatal and self-limiting malarial infections of mice. Immunology (1978) 1.08
Generation of T-helper cells in vitro. II. Analysis of supernates derived from T-helper cell cultures. J Exp Med (1977) 1.05
Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes. Clin Exp Immunol (1975) 0.95
Isolation and characterization of Fc-receptors shed from human peripheral mononuclear cells. Immunology (1978) 0.91
Immune elimination and enhanced antibody responses: functions of circulating IgA. Immunology (1980) 0.89
Clonal dominance and the preservation of clonal memory cells mediated by antigen-antibody. Immunology (1976) 0.86
Receptors for IgM on human lymphocytes. III. Specificity of receptors. Clin Exp Immunol (1979) 0.86
Immunosuppressive effect of syngeneic thymus cells on allograft rejection. Proc Natl Acad Sci U S A (1975) 0.83
Maternal inhibition of malaria vaccination in mice can be overcome by giving a second dose of vaccine. Immunology (1984) 0.79
[The leukocyte migration inhibition test (LMIT) in recurrent herpes simplex labialis. Comparison of the results of treatment with BCG and Levamisole (author's transl)]. Arch Dermatol Res (1979) 0.79
Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation. Infect Immun (1980) 0.78
Isoantiserum-augmented development of lymphocyte-mediated cytotoxicity. J Exp Med (1976) 0.75
Histocompatibility-linked immune response genes. Science (1972) 16.79
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur J Immunol (1971) 6.14
Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology (1970) 6.06
Regulatory effect of antibody on the immune response. Adv Immunol (1968) 6.03
Infectious immunological tolerance. Immunology (1971) 5.30
The allogeneic effect on immune responses: model for regulatory influences of T lymphocytes on the immune system. Transplant Rev (1972) 5.23
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes. Scand J Immunol (1972) 4.50
Isolation and partial characterization of lymphocyte surface immunoglobulins. J Exp Med (1972) 4.04
Cell interactions in the immune response in vitro. V. Specific collaboration via complexes of antigen and thymus-derived cell immunoglobulin. J Exp Med (1972) 3.57
Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response. J Immunol (1971) 3.48
Competition of 19S and 7S antigen receptors in the regulation of the primary immune response. J Exp Med (1968) 3.40
Quantitative features of a sandwich radioimmunolabeling technique for lymphocyte surface receptors. J Exp Med (1972) 3.28
Blocking of the lymphocyte receptor site for cell mediated hypersensitivity and transplantation reactions by anti-light chain sera. Nature (1969) 3.17
The immunoglobulin nature of the antigen recognition site on cells mediating transplantation immunity and delayed hypersentivity. J Immunol (1970) 3.08
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
THYMIC CHANGES IN THE MOUSE STRAIN NZB IN RELATION TO THE AUTO-IMMUNE STATE. J Pathol Bacteriol (1964) 2.86
Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice. Nature (1973) 2.85
Regulation of homocytotropic antibody formation in the rat. 3. Effect of thymectomy and splenectomy. J Immunol (1971) 2.61
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. J Immunol (1970) 2.59
Active suppression of immunoglobulin allotype synthesis. 3. Identification of T cells as responsible for suppression by cells from spleen, thymus, lymph node, and bone marrow. J Exp Med (1973) 2.57
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Role of the thymus in tolerance. X. "Suppressor" activity of antigen-stimulated rat thymocytes transferred to normal recipients. J Immunol (1973) 2.40
Thymus-derived (T) cell immunoglobulins. Presence of a receptor site for IgG and absence of large amounts of "buried" Ig determinants on T cells. J Exp Med (1972) 2.35
Differential stimulation of precursor cells and carrier-specific thymus-derived cell activity in the in vivo reponse to heterologous erythrocytes in mice. J Immunol (1972) 2.21
Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody. J Immunol (1971) 2.19
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
The elusive T cell receptor. Transplant Rev (1972) 2.14
Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells. J Exp Med (1973) 2.11
Adjuvant activity of erythrocyte isoantigens. Science (1967) 1.97
T cells can bind antigen via cytophilic IgM antibody made by B cells. J Immunol (1973) 1.95
Regulation of the immune response. I. Reduction in ability of specific antibody to inhibit long-lasting IgG immunological priming after removal of the Fc fragment. J Exp Med (1969) 1.93
The influence of antibodies on immunologic responses. I. The effect on the response to particulate antigen in the rabbit. J Exp Med (1967) 1.92
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Variable effects of anti-lymphocyte serum on humoral antibody formation: role of thymus dependency of antigen. J Immunol (1971) 1.80
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Antinuclear antibodies in mice. II. Transmission with spleen cells; inhibition or prevention with thymus or spleen cells. Immunology (1969) 1.76
Monospecificity of bone marrow-derived lymphocytes. J Exp Med (1973) 1.74
Immunoglobulins on the surface of thymus-derived cells engaged in the initiation of a humoral immune response. J Exp Med (1971) 1.73
Selective priming of T cells by chemically altered cell antigens. J Exp Med (1972) 1.69
Amplifying and suppressive effect of thymus cells. Nature (1971) 1.65
Blocking and redistribution ("capping") of antigen receptors on T and B lymphocytes by anti-immunoglobulin antibody. J Exp Med (1973) 1.63
Immunological enhancement: a study of blocking antibodies. Adv Immunol (1972) 1.59
The mechanism of antibody-induced stimulation and inhibition of the immune response. J Immunol (1971) 1.58
Immunoglobulin molecules on the surface of activated T lymphocytes in the rat. J Exp Med (1973) 1.53
Gross reactivity between synthetic T,GA-L and transplantation antigens in CBA Mice. Nat New Biol (1973) 1.46
Cell surface-associated gamma globulins in lymphocytes. IV. Lack of detection of surface globulin on B-cells and acquisition of surface G globulin by T-cells during primary response. J Immunol (1972) 1.45
Regulation of homocytotropic antibody formation in the rat. V, Cell cooperation in the anti-hapten homocytotropic antibody response. J Immunol (1971) 1.38
Hapten-specific augmentation of the anti-idiotype antibody response to hapten-myeloma protein conjugates in mice. Eur J Immunol (1973) 1.37
Serologically undetectable immune responses in transplantation. Transplant Proc (1972) 1.34
Active synthesis of immunoglobulin receptors for antigen by T lymphocytes. Nature (1974) 1.33
Immunologic approach to cancer. Transplant Proc (1970) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
Cooperation between carrier-reactive and hapten-sensitive cells in vitro. Nat New Biol (1971) 1.30
DNA synthetic response of thymocytes to a variety of antigens. J Immunol (1972) 1.30
SOME SIMILARITIES BETWEEN THE NEONATAL THYMECTOMY SYNDROME AND GRAFT-VERSUS-HOST DISEASE. J Reticuloendothel Soc (1964) 1.29
Inhibition of human mixed lymphocyte reaction by antibodies to immunoglobulin light chain determinants. Clin Exp Immunol (1971) 1.26
Regulation of the immune response. V. An analysis of the function of the Fc portion of antibody in suppression of an immune response with respect to interaction with components of the lymphoid system. Immunology (1971) 1.24
Immunoglobulin synthesis and secretion by cells in the mouse thymus that do not bear theta antigen. Proc Natl Acad Sci U S A (1973) 1.24
Regulation of the immune response. I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes. J Exp Med (1971) 1.23
Regulation of the immune response: suppressive and enhancing effects of passively administered antibody. J Exp Med (1971) 1.20
T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis. Transplant Rev (1972) 1.19
Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol (1973) 1.19
Induction of specific helper cells in vitro. Nat New Biol (1973) 1.13
Antigen-binding specificity of isolated cell-surface immunoglobulin from thymus cells activated to histocompatibility antigens. Proc Natl Acad Sci U S A (1972) 1.12
Cytophilic antibodies in passive aibody induced immune suppression or enhancement. Nature (1970) 1.12
Specific antibody-mediated effect on the immune response. Suppression and augmentation of the primary immune response in mice by different classes of antibodies. Immunology (1972) 1.11
SYNERGIC AND ANTAGONISTIC EFFECTS OF ISOANTIBODY UPON GRAFT-VERSUS-HOST DISEASE. Transplantation (1965) 1.10
Thymus dependency of antibody-mediated helper effect. J Immunol (1973) 1.09
Cooperation by mouse T lymphocytes: the role of antibody in T cell specificity. Eur J Immunol (1974) 1.03
Antigenic competition between heterologous erythrocytes. II. Effect of passive antibody administration. J Immunol (1971) 1.01
Hapten-carrier relationships of isoantigens. A model for immunological maturation based on the conversion of haptens of carriers by antibody. J Exp Med (1970) 1.01
Cross-reactions between erythrocytes at the T-cell level. Immunology (1973) 0.99
The long-term distribution of antibody-forming cells. Eur J Immunol (1972) 0.99
Suppression of delayed hypersensitivity reactions in bursectomized chickens by passively administered anti-immunoglobulin antisera. J Immunol (1973) 0.98
Regulation of the immune response with antigen specific IgM antibody: a dual role. J Immunol (1973) 0.94
Suppression or augmentation of the antihapten response in mice by antibodies of different specificities. J Exp Med (1973) 0.94
Effects of IgM on the in vivo and in vitro immune response. Proc Soc Exp Biol Med (1973) 0.93
Evidence for a preferential effect of cyclophosphamide on B-cells. Proc R Soc Med (1973) 0.91
The rosette cell response of several mouse strains to immunization with both sheep and pigeon erythrocytes; magnitude of errors caused by cytophilic antibody. Eur J Immunol (1972) 0.89
Antibody-mediated suppression of the immune response in vitro. IV. The effect of antibody fragments. J Immunol (1972) 0.88
Immunodeviation by passive antibody, an expression of selective immunodepression. II. Action of guinea pig IgG1 and IgG2 anticarrier antibodies. J Exp Med (1973) 0.88
Early antibody-forming cells of double specificity. Immunology (1971) 0.86
Immunological interaction of erythrocyte isoantigens: effects of passive antibody. Proc Soc Exp Biol Med (1969) 0.85
Comparison of the suppressive effect of thymus cells and the suppression by neonatal application of antigen. Eur J Immunol (1973) 0.84
Adaptive transfer of neonatally induced tolerance into normal mice. Cell Immunol (1973) 0.83
Suppression of the antibody response to SRBC with F(ab') 2 and IgG in vitro. J Immunol (1973) 0.81
Immunocompetent cells of the chicken. 3. Cooperation of carrier sensitized T cells from agammaglobulinemic donors with hapten immune B cells. J Immunol (1973) 0.79
Induction of hapten-specific B cell tolerance by low doses of hapten-carrier conjugate. Nature (1973) 0.77
A mechanism for the unresponsive state in BALB-c mice after repeated doses of sheep erythrocytes. J Immunol (1972) 0.76
Enhancement of an anti-hapten antibody response by an antiserum to the carrier protein. J Immunol (1973) 0.76
The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05
Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09
Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03
Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57
Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45
Strain differences in the immune response of mice. II. Responses by neonatal cells in irradiated adult hosts. Immunology (1968) 1.45
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol (1987) 1.42
Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Indirect immunofluorescence of mouse thymus-derived cells using heterologous anti-brain serum. Cell Immunol (1973) 1.38
Reactivity and crossreactivity of mouse helper T cells to malaria parasites. Immunology (1977) 1.36
Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology (1990) 1.35
Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol (1982) 1.34
Immunity to malaria. Br Med Bull (1982) 1.34
Antibody responses in mice protected against malaria by vaccination. Parasite Immunol (1979) 1.34
Antibody formation by bone marrow cells in irradiated mice. I. Thymus-dependent and thymus-independent responses to sheep erythrocytes. Immunology (1971) 1.31
Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation (1969) 1.30
Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol (1974) 1.27
The genetic basis of autoimmunity in NZB mice studied by progeny-testing. Clin Exp Immunol (1971) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun (1990) 1.21
Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant. Parasite Immunol (1986) 1.20
Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology (1994) 1.19
Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17
Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15
Two distinct types of non-specific immunosuppression in murine malaria. Clin Exp Immunol (1980) 1.14
Stimulation and suppression of response of mouse T cells to the schistosomules of Schistosoma mansoni during infection. Nature (1976) 1.14
Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology (1985) 1.14
Age-dependent changes in the relative affinity of anti-dinitrophenyl antibodies in mice. Immunology (1975) 1.13
B cells: subpopulations, tolerance, autoimmunity, and infection. Immunol Rev (1979) 1.13
Lymphocyte traffic and lymphocyte destruction in murine malaria. Immunology (1982) 1.13
Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 1.12
Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Clin Exp Immunol (1985) 1.12
Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol (1981) 1.11
Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect Immun (1992) 1.10
Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst. Infect Immun (1984) 1.10
Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett (1990) 1.09
Macrophages as effector cells in immunity to malaria. Immunol Lett (1985) 1.09
Changes in the capacity of macrophages and T cells to produce interleukins during murine malaria infection. Cell Immunol (1984) 1.06
Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro. Clin Exp Immunol (1982) 1.05
Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii. Clin Exp Immunol (1983) 1.04
Cooperation by mouse T lymphocytes: the role of antibody in T cell specificity. Eur J Immunol (1974) 1.03
Failure of malaria vaccination in mice born to immune mothers. Clin Exp Immunol (1982) 1.03
Antilymphocyte autoantibody in lethal mouse malaria and its suppression by non-lethal malaria. Parasite Immunol (1983) 1.02
Hyper-responsiveness in NZB mice to the experimental induction of anti-red cell autoantibody. Clin Exp Immunol (1977) 1.02
Early maturation of immune responses in neonatal New Zealand black (NZB) mice. Proc R Soc Med (1967) 1.02
Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection. Infect Immun (1994) 1.01
Polyclonal in vitro proliferative responses from nonimmune donors to Plasmodium falciparum malaria antigens require UCHL1+ (memory) T cells. Eur J Immunol (1990) 1.01
Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun (1987) 1.01
Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax. Infect Immun (1992) 1.01
Malaria: toxins, cytokines and disease. Parasite Immunol (1995) 1.01
Failure of malaria vaccination in mice born to immune mothers. II. Induction of specific suppressor cells by maternal IgG. Clin Exp Immunol (1983) 1.00
Cross-reactions between erythrocytes at the T-cell level. Immunology (1973) 0.99
Plasmodium yoelii and Plasmodium vinckei: the effects of nonspecific immunostimulation on murine malaria. Exp Parasitol (1977) 0.99
Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res (1989) 0.98
B cell-derived immunoglobulin on activated mouse T lymphocytes. Nature (1974) 0.97
Serum IL-2 inhibitor in mice. II. Molecular characteristics. Immunology (1985) 0.96
Development and suppression of a population of late-adhering macrophages in mouse malaria. Parasite Immunol (1979) 0.96
Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant. Infect Immun (1996) 0.96
Phospholipid-containing toxic malaria antigens induce hypoglycaemia. Clin Exp Immunol (1992) 0.96
Differential tolerance of thymus-independent and thymus-dependent antibody responses. Immunology (1978) 0.96
Interferon-gamma as an adjuvant in immunocompromised mice. Immunology (1989) 0.95
Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes. Clin Exp Immunol (1975) 0.95
Deficient cell-mediated immunity in adult NZB mice. Transplantation (1970) 0.95
Tumour necrosis factor and interleukin-6 production induced by components associated with merozoite proteins of Plasmodium falciparum. Parasite Immunol (1993) 0.93
Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs). Mol Genet Metab (2001) 0.92
The role of T cells in regulating immunoglobulin class and subclass. Immunology (1980) 0.92
Effective and ineffective immune responses to parasites: evidence from experimental models. Curr Top Microbiol Immunol (1978) 0.92
A novel adjuvant for use with a blood-stage malaria vaccine. Vaccine (1995) 0.91
Blood-stage malaria infection in diabetic mice. Clin Exp Immunol (1995) 0.91
DNA vaccination favours memory rather than effector B cell responses. Clin Exp Immunol (1999) 0.91
T-independent macrophage changes in murine malaria. Clin Exp Immunol (1983) 0.90
Changes in oxidative burst capacity during murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 0.90
Killing of blood-stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum. Infect Immun (1988) 0.90
C3 receptor. A marker of a thymus-dependent B-cell subpopulation. Clin Exp Immunol (1975) 0.89